Novo CEO pressed by Senate to chop costs of obesity, diabetes drugs CEO Lars Fruergaard Jørgensen instructed lawmakers the corporation would take into consideration new talks with insurers with regards to the record prices of Wegovy and copyright when they pledge to help keep the medicines on their own formularies. https://kethek.com/